Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Collaborators, Affiliations

Collaborators

Working Group for Renaming Diabetes Insipidus:
Hiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, Mark Gurnell, Deborah Cooper, Juliana Drummond, Miles Levy, Mark Gurnell, Ann McCormack, Joseph G Verbalis, John Newell-Price, John Wass

Affiliations

¹ Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
² Department of Pediatric Endocrinology, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
³ Great North Children's Hospital (GNCH), Newcastle upon Tyne NE1 4LP, UK.
⁴ Department of Endocrinology, University Hospital and University of Basel, CH-4031 Basel, Switzerland.
⁵ The Pituitary Foundation, Bristol BS1 5BB, UK.
⁶ Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG CEP 31270-901, Brazil.
⁷ Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
⁸ Department of Endocrinology, University Hospitals of Leicester NHS Trust, Leicester LE3 9QP, UK.
⁹ Department of Endocrinology, St Vincent's Hospital, Sydney, NSW 2010, Australia.
¹⁰ Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
¹¹ St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
¹² Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.
¹³ Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA.
¹⁴ Department of Endocrinology, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.

PMID: 36355385
PMCID: PMC9759163
DOI: 10.1210/clinem/dgac547

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Hiroshi Arima et al. J Clin Endocrinol Metab. 2022.

. 2022 Dec 17;108(1):1-3.

doi: 10.1210/clinem/dgac547.

Authors

Collaborators

Working Group for Renaming Diabetes Insipidus:
Hiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, Mark Gurnell, Deborah Cooper, Juliana Drummond, Miles Levy, Mark Gurnell, Ann McCormack, Joseph G Verbalis, John Newell-Price, John Wass

Affiliations

¹ Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
² Department of Pediatric Endocrinology, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
³ Great North Children's Hospital (GNCH), Newcastle upon Tyne NE1 4LP, UK.
⁴ Department of Endocrinology, University Hospital and University of Basel, CH-4031 Basel, Switzerland.
⁵ The Pituitary Foundation, Bristol BS1 5BB, UK.
⁶ Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG CEP 31270-901, Brazil.
⁷ Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
⁸ Department of Endocrinology, University Hospitals of Leicester NHS Trust, Leicester LE3 9QP, UK.
⁹ Department of Endocrinology, St Vincent's Hospital, Sydney, NSW 2010, Australia.
¹⁰ Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
¹¹ St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
¹² Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.
¹³ Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA.
¹⁴ Department of Endocrinology, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.

PMID: 36355385
PMCID: PMC9759163
DOI: 10.1210/clinem/dgac547

Abstract

Recent data show that patients with a diagnosis of diabetes insipidus (DI) are coming to harm. Here we give the rationale for a name change to arginine vasopressin deficiency and resistance for central and nephrogenic DI, respectively.

Keywords: arginine vasopressin deficiency; arginine vasopressin resistance; diabetes insipidus; nephrogenic; pituitary.

PubMed Disclaimer

References

1. Venturini PL, Capitanio GL, Boccardo E, Ferraro R, Rossato P, De CL. The amenorrhoea–galactorrhea syndrome: present diagnostic and therapeutic perspectives. Acta Eur Fertil. 1975;6(4):331–338. - PubMed
1. Matteson EL. Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schonlein, Wegener, Churg and Strauss, Horton, Takayasu, Behcet, and Kawasaki. Arthritis Care Res. 2000;13(4):237–245. - PubMed
1. Lu DW, Katz KA. Declining use of the eponym “Reiter's Syndrome” in the medical literature, 1998-2003. J Am Acad Dermatol. 2005;53(4):720–723. - PubMed
1. Woywodt A, Haubitz M, Haller H, Matteson EL. Wegener’s granulomatosis. Lancet. 2006:367(9519):1362–1366. - PubMed
1. Matteson EL. All medical eponyms should be abandoned. Presse Med. 2008:37(2 Pt 1):250–251. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Collaborators

Affiliations

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Authors

Collaborators

Affiliations

Abstract

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical